Previous close | 92.13 |
Open | 92.92 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1000 |
Day's range | 91.96 - 93.60 |
52-week range | 70.74 - 95.26 |
Volume | |
Avg. volume | 487,435 |
Market cap | 4.74B |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | 37.94 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
Haemonetics' (NYSE:HAE) stock is up by a considerable 12% over the past month. Given the company's impressive...
Recovery within the Hospital business and the favorable prospects of the Plasma franchise raise investors' optimism for Haemonetics (HAE).